Meta-analysis and systematic review: The administration of glucocorticoids, as a line of treatment for COVID-19 patients, could result in lowering mortality

References

• Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., Zhao, J., Ning, Q. . Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ, (2020, March, 26). 368, m1091. Erratum in: BMJ. 2020 Mar 31;368:m1295. PMID: 32217556; PMCID: PMC7190011. https://doi.org/10.1136/bmj.m1091
   PubMed Web of Science ®Google Scholar
• clinical guideline. https://wenku.baidu.com/view/920053946394dd88d0d233d4b14e852459fb3902.html
   Google Scholar
• Deng, Y., Liu, W., Liu, K., Fang, Y.Y., Shang, J., Zhou, L., Wang, K., Leng, F., Wei, S., Chen, L., Liu, H.G. . (2020, June, 5). Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: A retrospective study. Chinese Medical Journal, 133(11), 1261–19. PMID: 32209890; PMCID: PMC7289311. https://doi.org/10.1097/CM9.0000000000000824
   PubMed Web of Science ®Google Scholar
• Dequin, P. F., Heming, N., Meziani, F., Plantefeve, G., Voiriot, G., Badie,J. ,Francois, B., Aubron, C., Ricard, J.D., Ehrmann, S., Jouan, Y., Guillon, A., Leclerc, M., Coffre, C., Bourgoin, H., Lengelle, C., Caille-Fenerol, C., Tavernier, E., Zohar, S., Giraudeau, B., Annane, D. et al . (2020, October, 6). Effect of hydrocortisone on 21-day mortality or respiratory support among critically Ill patients with COVID-19: A randomized clinical trial. JAMA, 324(13), 1298–1306. PMID: 32876689; PMCID: PMC7489432. https://doi.org/10.1001/jama.2020.16761
   PubMed Web of Science ®Google Scholar
• Edalatifard, M., Akhtari, M., Salehi, M., Naderi, Z., Jamshidi, A., Mostafaei, S., Najafizadeh, S.R., Farhadi, E., Jalili, N., Esfahani, M., Rahimi, B., Kazemzadeh, H., Mahmoodi, Aliabadi M., Ghazanfari, T., Sattarian, M., Ebrahimi, Louyeh H., Raeeskarami, S.R., Jamalimoghadamsiahkali, S., Khajavirad, N., Mahmoudi, M., Rostamian, A. . (2020, December, 24). Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: Results from a randomised controlled clinical trial. European Respiratory Journal, 56(6), 2002808. PMID: 32943404; PMCID: PMC7758541. https://doi.org/10.1183/13993003.02808-2020
   PubMed Web of Science ®Google Scholar
• Ellinghaus, D., Degenhardt, F., Bujanda, L., Buti, M., Albilos, A., Invernizzi, P., Fernandez, J., Prati, D., Baselli, G., Asselta, R., Grimsrud, M.M., Milani, C., Aziz, F., Kassens, J., May, S., Wendorff, M., Wienbrandt, L., Uellendahl-Werth, F., Zheng, T., Yi, X., de Pablo, R. et al . (2020, Oct. 15). Genomewide association study of severe COVID-19 with respiratory failure. The New England Journal of Medicine 383(16), 1522–1534. https://doi.org/10.1056/NEJMoa2020283
   Web of Science ®Google Scholar
• Jeronimo, C. M. P., Farias, M. E. L., Val, F. F. A., Sampaio, V.S., Alexandre, M.A.A., Melo, G.C., Safe, I.P., Borba, M.G.S., Netto, R.L.A., Maciel, A.B.S., Neto, J.R.S., Oliveira, LB., Figueiredo, E.FG, Oliveira, Dinelly K.M., de Almeida, Rodrigues M.G., Brito, M., Mourao, M.P.G., Pivoto, Joao G.A., Hajjar, L.A., Bassat, Q., Romero, G.A.S. et al . (2021, May, 4). Methylprednisolone as adjunctive therapy for patients hospitalized with Coronavirus disease 2019 (COVID-19; Metcovid): A randomized, double-blind, phase IIb, placebo-controlled trial. Clinical Infectious Diseases, 72(9), e373–e381. PMID: 32785710; PMCID: PMC7454320. https://doi.org/10.1093/cid/ciaa1177
   PubMed Web of Science ®Google Scholar
• Keller, M. J., Kitsis, E. A., Arora, S., Chen, J.-T., Agarwal, S., Ross, M. J., Tomer, Y., & Southern, W. (2020, August). Effect of systemic glucocorticoids on mortality or mechanical ventilation in patients with COVID-19. Journal of Hospital Medicine, 15 (8), 489–493. PMID: 32804611; PMCID: PMC7518134 https://doi.org/10.12788/jhm.3497
   PubMed Web of Science ®Google Scholar
• Li, Q, Guan, X, Wu, P, Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K.S.M., Lau, E.H.Y., Wong, J.Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., Tu, W., Chen, C. et al . (2020). Early transmission dynamics in Wuhan, china, of novel Coronavirus–infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Nelson, B. C., Laracy, J., Shoucri, S., Dietz, D., Zucker, J., Patel, N., Sobieszczyk, M.E., Kubin, C.J., Gomez-Simmonds, A. . (2021, May, 4). Clinical outcomes associated with methylprednisolone in mechanically ventilated patients with COVID-19. Clinical Infectious Diseases, 72(9), e367–e372. PMID: 32772069; PMCID: PMC7454332. https://doi.org/10.1093/cid/ciaa1163
   Web of Science ®Google Scholar
• Parasher, A. (2021, May). COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment. Postgraduate Medical Journal, 97 (1147), 312–320. Epub 2020 Sep 25. PMID: 32978337 https://doi.org/10.1136/postgradmedj-2020-138577
   PubMed Web of Science ®Google Scholar
• Pei, L., Zhang, S., Huang, L., Geng, X., Ma, L., Jiang, W., Li, W., Chen, D. . (2020, September, 30). Antiviral agents, glucocorticoids, antibiotics, and intravenous immunoglobulin in 1142 patients with coronavirus disease 2019: A systematic review and meta-analysis. Polish Archives of Internal Medicine, 130(9), 726–733. Epub 2020 Aug 4. PMID: 32749826. https://doi.org/10.20452/pamw.15543
   PubMedGoogle Scholar
• Ramiro, S., Mostard, R. L. M., Magro-Checa, C., van Dongen, C. M. P., Dormans, T., Buijs, J., Gronenschild , M., de Kruif, M. D., van Haren, E. H. J., van Kraaij, T., Leers, M. P. G., Peeters, R., Wong, D. R., Landewe, R. B. M. . (2020, September). Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: Results of the CHIC study. Annals of the Rheumatic Diseases, 79(9), 1143–1151. Epub 2020 Jul 20. PMID: 32719045; PMCID: PMC7456552. https://doi.org/10.1136/annrheumdis-2020-218479
   PubMed Web of Science ®Google Scholar
• RECOVERY Collaborative Group . (2021, February, 25). Dexamethasone in hospitalized patients with Covid-19. The New England Journal of Medicine, 384(8), 693–704. Epub 2020 Jul 17. PMID: 32678530; PMCID: PMC7383595. https://doi.org/10.1056/NEJMoa2021436
   PubMed Web of Science ®Google Scholar
• Russell, C. D., Millar, J. E., & Baillie, J. K. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. (2020). The Lancet, 395(10223), 473–475. British edition. https://doi.org/10.1016/S0140-6736(20)30317-2
   PubMed Web of Science ®Google Scholar
• Shang, L., Zhao, J., Hu, Y., Du, R., & Cao, B. (2020). On the use of corticosteroids for 2019-nCoV pneumonia. The Lancet, 395(10225), 683–684. https://doi.org/10.1016/S0140-6736(20)30361-5
   PubMed Web of Science ®Google Scholar
• Silva Júnior ML, M., Souza, L. M. A., Remc, D., Valente, R. G. D. M., & Melo, T. S. (2021, June). Review on therapeutic targets for COVID-19: Insights from cytokine storm. Postgraduate Medical Journal, 97 (1148), 391–398. Epub 2020 Oct 2. PMID: 33008960 https://doi.org/10.1136/postgradmedj-2020-138791
   Web of Science ®Google Scholar
• WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working GroupSterne, J. A. C., Murthy, S., Diaz, J. V., Slutsky, A. .S, Villar, J., Angus, D. C., Annane, D., Azevedo, L. C. P., Berwanger, O., Cavalcanti, A. B., Dequin, P. F., Du, B., Emberson, J., Fisher, D., Giraudeau, B., Gordon, A. C., Granholm, A., Green, C., Haynes, R., Heming, N., Higgins, J. P. .T et al . (2020, October, 6). Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: A meta-analysis. JAMA, 324(13), 1330–1341. PMID: 32876694; PMCID: PMC7489434. https://doi.org/10.1001/jama.2020.17023
   PubMed Web of Science ®Google Scholar
• The writing committee for the REMAP-CAP investigators. (2020). Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial. JAMA, 324(13), 1317–1329. https://doi.org/10.1001/jama.2020.17022
   PubMed Web of Science ®Google Scholar
• Tomazini, B. M., Maia, I. S., Cavalcanti, A. B., Berwanger, O., Rosa, R. G., Veiga, V. C., Avezum, A., Lopes, R. D., Bueno, F. R., Silva, M. V. A. .O, Baldassare, F. P., Costa, E. L. V., Moura, R. A. B., Honorato, M. O., Costa, A. N., Damiani, L. P., Lisboa, T., Kawano-Dourado, L., Zampieri, F. G., Olivato, G. B., Righy, C. et al . (2020, October, 6). COALITION COVID-19 Brazil III investigators. Effect of dexamethasone on days Alive and Ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA, 324(13), 1307–1316. PMID: 32876695; PMCID: PMC7489411. https://doi.org/10.1001/jama.2020.17021
   PubMed Web of Science ®Google Scholar
• WHO, WHO/2019-nCoV/therapeutics/2021.3, 24 September 2021
   Google Scholar
• Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., Zhang, Y., Song, J., Wang, S., Chao, Y., Yang, Z., Xu, J., Zhou, X., Chen, D., Xiong, W., Xu, L., Zhou, F. et al . (2020). Risk factors associated with acute respiratory distress syndrome and death in patients With Coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180(7), 934–943. https://doi.org/10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Yan, J., Liu, A., Huang, J., Wu, J., & Fan, H. (2020, May, 13). Research progress of drug treatment in novel Coronavirus Pneumonia. AAPS Pharmaceutical Science and Technology, 21(4), PMID: 32405780; PMCID: PMC7220569, 130. https://doi.org/10.1208/s12249-020-01679-z
   Web of Science ®Google Scholar
• Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., Yu, T., Wang, Y., Pan, S., Zou, X., Yuan, S., Shang, Y. . (2020, May). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine, 8(5), 475–481. Epub 2020 Feb 24. Erratum in: Lancet Respir Med. 2020 Apr;8(4):e26. PMID: 32105632; PMCID: PMC7102538. https://doi.org/10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Zhao, J. P., Hu, Y., Du, R. H., Chen, Z. S., Jin, Y., Zhou, M., Zhang, J., Qu, J. M., Cao, B. . (2020). Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 43(3), 183–184. https://doi.org/10.3760/cma.j.1001-0939.2020.03.008
   PubMedGoogle Scholar
• Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020, March, 28). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. PMID: 32171076; PMCID: PMC7270627, 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
   PubMed Web of Science ®Google Scholar